表紙：鎌状赤血球症治療市場- 治療方法別、疾患別、エンドユーザー別、2023-2032年予測

市場調査レポート

商品コード

1336641

鎌状赤血球症治療市場- 治療方法別、疾患別、エンドユーザー別、2023-2032年予測

Sickle Cell Disease Treatment Market - By Treatment Modality [Blood Transfusion, Pharmacotherapy (Hydroxyurea, Oxybryta, Endari), Bone Marrow Transplant], By Disease (Sickle Cell Anemia, Hemoglobin Sickle C), By End-user & Forecast, 2023-2032

出版日: 2023年05月15日
発行: Global Market Insights Inc.
ページ情報: 英文 190 Pages
納期: 2～3営業日

カスタマイズ可能

価格

PDF & Excel (Single User License)

USD 4,850 698,691円

レポートPDFおよびExcelを1名様のみがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Multi User License)

USD 6,050 871,563円

レポートPDFおよびExcelを5名様までがご利用頂けるライセンスです。PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

PDF & Excel (Enterprise User License)

USD 8,350 1,202,901円

レポートPDFおよびExcelを同一企業内のすべての方にご利用頂けるライセンスです。 100％子会社は同一企業とみなされます。 PDFおよびExcel内のテキスト等のコピーは可能です。PDFおよびExcelの印刷は可能ですが、印刷したもののご利用はPDFおよびExcelのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=144.06円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

世界の鎌状赤血球症治療市場は、2023年から2032年にかけて安定した成長率を示すと思われます。

特にサハラ以南のアフリカと中東の一部で鎌状赤血球症の有病率が高く、効果的な治療オプションが求められています。CDCによると、SCDは推定10万人のアメリカ人を罹患させています。また、この病気は黒人またはアフリカ系アメリカ人の出産365件に1件の割合で発生しています。

医学研究と技術の進歩により、遺伝子治療や分子標的薬などの新しい治療法が開発され、患者の予後が改善されています。また、政府の取り組みや製薬会社との協力により、治療選択肢へのアクセスが増加しています。さらに、病気の早期診断と早期管理の重要性に対する医療従事者や患者の意識の高まりが、鎌状赤血球症治療市場における革新的な治療法の需要をさらに促進しています。

市場全体のシェアは、治療方法、疾患、エンドユーザー、地域に基づいて分類されます。

治療方法に基づくと、骨髄移植セグメントは2023年から2032年にかけて市場収益に大きく貢献します。この治療法は、鎌状赤血球症の治癒の可能性を提供するもので、欠損した幹細胞を適合するドナーの健康な幹細胞と置き換えるものです。この治療法の認知度が高まるにつれ、より多くの患者や医療従事者が骨髄移植を実行可能な解決策として検討するようになっています。移植技術が進歩し、適合基準がよりよく理解されるようになったことで、成功率は向上し、骨髄移植はますます求められる選択肢となっています。

疾患別では、ヘモグロビン鎌状赤血球症（HbSC）分野が2023年から2032年にかけて高い成長率を示し、2032年までに鎌状赤血球症治療市場シェアを独占する可能性があります。HbSCは鎌状赤血球症の軽症型であるが、合併症を引き起こし、罹患者のQOLに影響を与える可能性があります。鎌状赤血球症に対する認識と理解が深まるにつれ、症状を管理し患者の全体的な幸福を向上させるための標的療法や支持療法に対するニーズが高まっており、長期的には同分野の成長に有利に働くと思われます。

エンドユーザーに関しては、鎌状赤血球症治療業界の専門クリニック部門は2032年までに適正な評価を記録すると思われます。これらのクリニックは、鎌状赤血球症の管理における専門的なケアと専門知識を提供し、患者に包括的な治療オプションとサポートを提供します。個別ケアとオーダーメイドの治療計画に重点を置く専門クリニックは、患者の転帰と生活の質の向上に重要な役割を果たしています。鎌状赤血球病に対する専門的治療の重要性に対する認識が高まっていることから、鎌状赤血球症治療市場でもこうしたクリニックの需要が高まっています。

地域別では、欧州の鎌状赤血球症治療市場は、同地域における鎌状赤血球病に対する認識の高まりと診断の改善により、予測期間中に牽引力を増すと思われます。同地域の強力なヘルスケアインフラと先進医療研究・技術へのアクセスが、革新的な治療法の開発と利用可能性を支えています。さらに、政府の取り組みや製薬企業との提携が、この分野の研究開発を促進しています。患者の転帰を改善し、生活の質を向上させることに重点が置かれつつあることが、欧州における鎌状赤血球症治療の需要を牽引しています。

業界情勢、2018年～2032年
業界への影響要因
- 促進要因
  - 鎌状赤血球症の有病率の増加
  - 鎌状赤血球症治療薬の研究開発活動の増加
  - ヘルスケア支出の増加と政府の取り組み
- 業界の潜在的リスク＆課題
  - 治療に伴う高コスト
  - 鎌状赤血球症治療薬に伴う副作用
成長可能性分析
COVID-19影響分析
臨床試験分析
規制状況
ポーター分析
PESTEL分析

第4章競合情勢、2022年

イントロダクション
企業マトリックス分析
世界企業シェア分析
競合のポジショニング・マトリックス
戦略ダッシュボード

第5章鎌状赤血球症治療市場の推定・予測：治療方法別

主要動向
輸血
薬物療法
- 薬剤タイプ別
  - ヒドロキシ尿素
  - オキシブライタ
  - アダクベオ
  - エンダリ
  - その他の薬物療法
- 投与経路別
  - 経口
  - 非経口
骨髄移植

第6章鎌状赤血球症治療薬市場推計・予測：疾患タイプ別

主要動向
鎌状赤血球貧血
ヘモグロビン鎌状赤血球症（HbSC）
その他の疾患タイプ

第7章鎌状赤血球症治療薬市場の推定・予測：エンドユーザー別

主要動向
病院
専門クリニック
その他のエンドユーザー

第8章鎌状赤血球症治療薬市場の推定・予測：地域別

主要動向
北米
- 米国
- カナダ
欧州
- ドイツ
- 英国
- フランス
- スペイン
- イタリア
- スイス
- その他欧州
アジア太平洋
- 中国
- 日本
- インド
- オーストラリア
- 韓国
- その他アジア太平洋地域
ラテンアメリカ
- ブラジル
- メキシコ
- その他ラテンアメリカ
中東・アフリカ
- 南アフリカ
- サウジアラビア
- その他のMEA

第9章企業プロファイル

Pfizer, Inc.
Novartis AG
Emmaus Medical, Inc.
Medunik USA, Inc.
Bristol-Myers Squibb Company
Bluebird Bio, Inc.
Agios Pharmaceuticals
CRISPR Therapeutics
Vifor Pharma
Editas Medicine Inc.

図表

Data Tables

TABLE 1 Product mapping
TABLE 2 Market revenue, by treatment modality (2022)
TABLE 3 Market revenue, by disease type (2022)
TABLE 4 Market revenue, by end-user (2022)
TABLE 5 Market share, by region (2022)
TABLE 6 Global sickle cell disease treatment market size, by region, 2018 - 2022 (USD Million)
TABLE 7 Global sickle cell disease treatment market size, by region, 2023 - 2032 (USD Million)
TABLE 8 Global sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 9 Global sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 10 Global sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 11 Global sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 12 Global sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 13 Global sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 14 Industry impact forces
TABLE 15 Competitive benchmarking of major market players
TABLE 16 Competitive positioning matrix: Classification criteria
TABLE 17 Strategic outlook matrix: Classification criteria
TABLE 18 Blood transfusion market size, 2018 - 2022 (USD Million)
TABLE 19 Blood transfusion market size, 2023 - 2032 (USD Million)
TABLE 20 Pharmacotherapy market size, 2018 - 2022 (USD Million)
TABLE 21 Pharmacotherapy market size, 2023 - 2032 (USD Million)
TABLE 22 Pharmacotherapy market size, by drug type, 2018 - 2022 (USD Million)
TABLE 23 Pharmacotherapy market size by drug type, 2023 - 2032 (USD Million)
TABLE 24 Hydroxyurea market size, 2018 - 2022 (USD Million)
TABLE 25 Hydroxyurea market size, 2023 - 2032 (USD Million)
TABLE 26 Oxybryta market size, 2018 - 2022 (USD Million)
TABLE 27 Oxybryta market size, 2023 - 2032 (USD Million)
TABLE 28 Adakveo market size, 2018 - 2022 (USD Million)
TABLE 29 Adakveo market size, 2023 - 2032 (USD Million)
TABLE 30 Endari market size, 2018 - 2022 (USD Million)
TABLE 31 Endari market size, 2023 - 2032 (USD Million)
TABLE 32 Other pharmacotherapies market size, 2018 - 2022 (USD Million)
TABLE 33 Other pharmacotherapies market size, 2023 - 2032 (USD Million)
TABLE 34 Pharmacotherapy market size, by route of administration, 2018 - 2022 (USD Million)
TABLE 35 Pharmacotherapy market size, by route of administration, 2023 - 2032 (USD Million)
TABLE 36 Oral market size, 2018 - 2022 (USD Million)
TABLE 37 Oral market size, 2023 - 2032 (USD Million)
TABLE 38 Parenteral market size, 2018 - 2022 (USD Million)
TABLE 39 Parenteral market size, 2023 - 2032 (USD Million)
TABLE 40 Bone marrow transplant market size, 2018 - 2022 (USD Million)
TABLE 41 Bone marrow transplant market size, 2023 - 2032 (USD Million)
TABLE 42 Sickle cell anemia market size, 2018 - 2022 (USD Million)
TABLE 43 Sickle cell anemia market size, 2023 - 2032 (USD Million)
TABLE 44 Hemoglobin sickle C disease (HbSC) market size, 2018 - 2022 (USD Million)
TABLE 45 Hemoglobin sickle C disease (HbSC) market size, 2023 - 2032 (USD Million)
TABLE 46 Other disease types market size, 2018 - 2022 (USD Million)
TABLE 47 Other disease types market size, 2023 - 2032 (USD Million)
TABLE 48 Hospitals market size, 2018 - 2022 (USD Million)
TABLE 49 Hospitals market size, 2023 - 2032 (USD Million)
TABLE 50 Specialty clinics market size, 2018 - 2022 (USD Million)
TABLE 51 Specialty clinics market size, 2023 - 2032 (USD Million)
TABLE 52 Other end-users market size, 2018 - 2022 (USD Million)
TABLE 53 Other end-users market size, 2023 - 2032 (USD Million)
TABLE 54 North America sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 55 North America sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 56 North America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 57 North America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 58 North America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 59 North America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 60 North America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 61 North America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 62 North America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 63 North America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 64 North America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 65 North America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 66 U.S. sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 67 U.S. sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 68 U.S. sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 69 U.S. sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 70 U.S. sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 71 U.S. sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 72 U.S. sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 73 U.S. sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 74 U.S. sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 75 U.S. sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 76 Canada sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 77 Canada sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 78 Canada sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 79 Canada sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 80 Canada sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 81 Canada sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 82 Canada sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 83 Canada sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 84 Canada sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 85 Canada sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 86 Europe sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 87 Europe sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 88 Europe sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 89 Europe sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 90 Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 91 Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 92 Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 93 Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 94 Europe sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 95 Europe sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 96 Europe sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 97 Europe sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 98 Germany sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 99 Germany sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 100 Germany sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 101 Germany sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 102 Germany sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 103 Germany sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 104 Germany sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 105 Germany sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 106 Germany sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 107 Germany sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 108 UK sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 109 UK sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 110 UK sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 111 UK sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 112 UK sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 113 UK sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 114 UK sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 115 UK sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 116 UK sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 117 UK sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 118 France sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 119 France sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 120 France sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 121 France sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 122 France sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 123 France sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 124 France sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 125 France sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 126 France sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 127 France sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 128 Spain sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 129 Spain sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 130 Spain sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 131 Spain sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 132 Spain sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 133 Spain sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 134 Spain sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 135 Spain sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 136 Spain sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 137 Spain sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 138 Italy sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 139 Italy sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 140 Italy sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 141 Italy sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 142 Italy sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 143 Italy sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 144 Italy sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 145 Italy sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 146 Italy sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 147 Italy sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 148 Switzerland sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 149 Switzerland sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 150 Switzerland sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 151 Switzerland sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 152 Switzerland sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 153 Switzerland sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 154 Switzerland sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 155 Switzerland sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 156 Switzerland sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 157 Switzerland sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 158 Rest of Europe sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 159 Rest of Europe sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 160 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 161 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 162 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 163 Rest of Europe sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 164 Rest of Europe sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 165 Rest of Europe sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 166 Rest of Europe sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 167 Rest of Europe sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 168 Asia Pacific sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 169 Asia Pacific sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 170 Asia Pacific sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 171 Asia Pacific sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 172 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 173 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 174 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 175 Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 176 Asia Pacific sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 177 Asia Pacific sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 178 Asia Pacific sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 179 Asia Pacific sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 180 China sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 181 China sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 182 China sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 183 China sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 184 China sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 185 China sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 186 China sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 187 China sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 188 China sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 189 China sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 190 Japan sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 191 Japan sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 192 Japan sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 193 Japan sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 194 Japan sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 195 Japan sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 196 Japan sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 197 Japan sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 198 Japan sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 199 Japan sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 200 India sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 201 India sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 202 India sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 203 India sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 204 India sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 205 India sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 206 India sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 207 India sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 208 India sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 209 India sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 210 Australia sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 211 Australia sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 212 Australia sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 213 Australia sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 214 Australia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 215 Australia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 216 Australia sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 217 Australia sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 218 Australia sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 219 Australia sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 220 South Korea sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 221 South Korea sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 222 South Korea sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 223 South Korea sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 224 South Korea sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 225 South Korea sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 226 South Korea sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 227 South Korea sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 228 South Korea sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 229 South Korea sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 230 Rest of Asia Pacific sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 231 Rest of Asia Pacific sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 232 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 233 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 234 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 235 Rest of Asia Pacific sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 236 Rest of Asia Pacific sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 237 Rest of Asia Pacific sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 238 Rest of Asia Pacific sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 239 Rest of Asia Pacific sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 240 Latin America sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 241 Latin America sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 242 Latin America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 243 Latin America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 244 Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 245 Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 246 Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 247 Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 248 Latin America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 249 Latin America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 250 Latin America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 251 Latin America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 252 Brazil sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 253 Brazil sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 254 Brazil sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 255 Brazil sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 256 Brazil sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 257 Brazil sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 258 Brazil sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 259 Brazil sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 260 Brazil sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 261 Brazil sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 262 Mexico sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 263 Mexico sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 264 Mexico sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 265 Mexico sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 266 Mexico sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 267 Mexico sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 268 Mexico sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 269 Mexico sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 270 Mexico sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 271 Mexico sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 272 Rest of Latin America sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 273 Rest of Latin America sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 274 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 275 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 276 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 277 Rest of Latin America sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 278 Rest of Latin America sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 279 Rest of Latin America sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 280 Rest of Latin America sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 281 Rest of Latin America sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 282 MEA sickle cell disease treatment market size, by country, 2018 - 2022 (USD Million)
TABLE 283 MEA sickle cell disease treatment market size, by country, 2023 - 2032 (USD Million)
TABLE 284 MEA sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 285 MEA sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 286 MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 287 MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 288 MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 289 MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 290 MEA sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 291 MEA sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 292 MEA sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 293 MEA sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 294 South Africa sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 295 South Africa sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 296 South Africa sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 297 South Africa sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 298 South Africa sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 299 South Africa sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 300 South Africa sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 301 South Africa sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 302 South Africa sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 303 South Africa sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 304 Saudi Arabia sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 305 Saudi Arabia sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 306 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 307 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 308 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 309 Saudi Arabia sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 310 Saudi Arabia sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 311 Saudi Arabia sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 312 Saudi Arabia sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 313 Saudi Arabia sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)
TABLE 314 Rest of MEA sickle cell disease treatment market size, by treatment modality, 2018 - 2022 (USD Million)
TABLE 315 Rest of MEA sickle cell disease treatment market size, by treatment modality, 2023 - 2032 (USD Million)
TABLE 316 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2018 - 2022 (USD Million)
TABLE 317 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by drug type, 2023 - 2032 (USD Million)
TABLE 318 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2018 - 2022 (USD Million)
TABLE 319 Rest of MEA sickle cell disease treatment market size, pharmacotherapy by route of administration, 2023 - 2032 (USD Million)
TABLE 320 Rest of MEA sickle cell disease treatment market size, by disease type, 2018 - 2022 (USD Million)
TABLE 321 Rest of MEA sickle cell disease treatment market size, by disease type, 2023 - 2032 (USD Million)
TABLE 322 Rest of MEA sickle cell disease treatment market size, by end-user, 2018 - 2022 (USD Million)
TABLE 323 Rest of MEA sickle cell disease treatment market size, by end-user, 2023 - 2032 (USD Million)

Charts & Figures

FIG 1 GMI report coverage: Critical research elements
FIG 2 Top-down approach
FIG 3 Market estimation and forecast methodology
FIG 4 Market forecasting methodology
FIG 5 Breakdown of primary participants
FIG 6 Sickle cell disease treatment industry 360 degree synopsis, 2018 - 2032
FIG 7 Growth potential analysis, by treatment modality
FIG 8 Growth potential analysis, by disease type
FIG 9 Growth potential analysis, by end-user
FIG 10 Porter's analysis
FIG 11 PESTEL analysis
FIG 12 Company matrix analysis, 2022
FIG 13 Global Company market share analysis, 2022
FIG 14 Competitive positioning matrix, 2022
FIG 15 Strategic dashboard, 2022

Product Code: 5697

Global Sickle Cell Disease Treatment Market will have a stable growth rate from 2023-2032. The high prevalence of sickle cell disease, particularly in sub-Saharan Africa and some parts of the Middle East, demands effective treatment options. According to CDC, SCD affects an estimated 100,000 Americans. Also, the disease occurs in about 1 in every 365 Black or African American births.

Advancements in medical research and technology have led to the development of novel therapies, including gene therapies and targeted drugs, improving patient outcomes. In addition, government initiatives and collaborations with pharmaceutical companies have facilitated increased access to treatment options. Moreover, growing awareness among healthcare professionals and patients about the importance of early diagnosis and management of the disease has further fuelled the demand for innovative treatments in the Sickle Cell Disease Treatment Market.

The overall market share is classified based on treatment modality, disease, end-user, and region.

Based on treatment modality, the bone marrow transplant segment will contribute significantly to the market revenue from 2023 to 2032. This treatment option offers a potential cure for sickle cell disease by replacing defective stem cells with healthy ones from a compatible donor. As awareness of this therapeutic approach grows, more patients and healthcare professionals are considering bone marrow transplants as a viable solution. Advances in transplant techniques and a better understanding of matching criteria have improved success rates, making bone marrow transplants an increasingly sought-after option.

By disease, the hemoglobin sickle C disease (HbSC) segment will show a high growth rate from 2023-2032 and could dominate the sickle cell disease treatment market share by 2032. HbSC is a milder form of sickle cell disease, but it can still cause complications and affect the quality of life for affected individuals. As awareness and understanding of HbSC increase, there is a growing need for targeted therapies and supportive care options to manage symptoms and improve patients' overall well-being, which will favor segment growth in the long run.

Regarding end-user, the specialty clinics segment of the sickle cell treatment industry will record a decent valuation by 2032. These clinics offer specialized care and expertise in managing sickle cell disease, providing comprehensive treatment options and support to patients. With a focus on personalized care and tailored treatment plans, specialty clinics play a crucial role in improving patient outcomes and quality of life. The rising awareness of the importance of specialized care for sickle cell disease has led to a growing demand for these clinics in the Sickle Cell Disease Treatment Market.

Regionally, the Europe sickle cell disease treatment market will gain traction during the forecast period due to increasing awareness and improved diagnosis of sickle cell disease in the region. The region's strong healthcare infrastructure and access to advanced medical research and technologies support the development and availability of innovative therapies. Additionally, government initiatives and collaborations with pharmaceutical companies promote research and development in the field. The growing focus on improving patient outcomes and enhancing quality of life drives the demand for sickle cell disease treatment in Europe.

Chapter 1 Methodology & Scope

1.1 Market definitions
1.2 Base estimates and calculations
1.3 Forecast calculations
1.4 Data sources
- 1.4.1 Secondary
  - 1.4.1.1 Paid sources
  - 1.4.1.2 Public sources
- 1.4.2 Primary

Chapter 2 Executive Summary

2.1 Sickle cell disease treatment industry 360 degree synopsis, 2018 - 2032 (USD Million)
- 2.1.1 Business trends
- 2.1.2 Region trends
- 2.1.3 Treatment modality trends
- 2.1.4 Disease type trends
- 2.1.5 End-user trends

Chapter 3 Sickle Cell disease Treatment Market Insights

3.1 Industry landscape, 2018 - 2032 (USD Million)
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Increasing prevalence of sickle cell disease
  - 3.2.1.2 Increasing R&D activities in drug development for sickle cell disease
  - 3.2.1.3 Increasing healthcare expenditure and government initiatives
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with the treatment
  - 3.2.2.2 Side effects associated with sickle cell disease treatment drugs
3.3 Growth potential analysis
- 3.3.1 By treatment modality
- 3.3.2 By disease type
- 3.3.3 By end-user
3.4 COVID-19 impact analysis
3.5 Clinical trial analysis
3.6 Regulatory landscape
3.7 Porter's analysis
3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2022

4.1 Introduction
4.2 Company matrix analysis, 2022
4.3 Global company market share analysis, 2022
4.4 Competitive positioning matrix, 2022
4.5 Strategic dashboard, 2022

Chapter 5 Sickle Cell Disease Treatment Market Estimates and Forecast, By Treatment Modality (USD Million)

5.1 Key trends, by treatment modality
5.2 Blood transfusion
5.3 Pharmacotherapy
- 5.3.1 By drug type
  - 5.3.1.1 Hydroxyurea
  - 5.3.1.2 Oxybryta
  - 5.3.1.3 Adakveo
  - 5.3.1.4 Endari
  - 5.3.1.5 Other pharmacotherapies
- 5.3.2 By route of administration
  - 5.3.2.1 Oral
  - 5.3.2.2 Parenteral
5.4 Bone marrow transplant

Chapter 6 Sickle Cell Disease Treatment Market Estimates and Forecast, By Disease Type (USD Million)

6.1 Key trends, by disease type
6.2 Sickle cell anemia
6.3 Hemoglobin sickle C disease (HbSC)
6.4 Other disease types

Chapter 7 Sickle Cell Disease Treatment Market Estimates and Forecast, By End-user (USD Million)

7.1 Key trends, by end-user
7.2 Hospitals
7.3 Specialty clinics
7.4 Other end-users

Chapter 8 Sickle Cell Disease Treatment Market Estimates and Forecast, By Region (USD Million)

8.1 Key trends, by region
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 Switzerland
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 China
- 8.4.2 Japan
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East & Africa
- 8.6.1 South Africa
- 8.6.2 Saudi Arabia
- 8.6.3 Rest of MEA

Chapter 9 Company Profiles

9.1 Pfizer, Inc.
9.2 Novartis AG
9.3 Emmaus Medical, Inc.
9.4 Medunik USA, Inc.
9.5 Bristol-Myers Squibb Company
9.6 Bluebird Bio, Inc.
9.7 Agios Pharmaceuticals
9.8 CRISPR Therapeutics
9.9 Vifor Pharma
9.10 Editas Medicine Inc.

鎌状赤血球症治療市場- 治療方法別、疾患別、エンドユーザー別、2023-2032年予測

Sickle Cell Disease Treatment Market - By Treatment Modality [Blood Transfusion, Pharmacotherapy (Hydroxyurea, Oxybryta, Endari), Bone Marrow Transplant], By Disease (Sickle Cell Anemia, Hemoglobin Sickle C), By End-user & Forecast, 2023-2032

目次

第1章調査手法と調査範囲

第2章エグゼクティブサマリー

第3章鎌状赤血球症治療市場の洞察

第4章競合情勢、2022年

第5章鎌状赤血球症治療市場の推定・予測：治療方法別

第6章鎌状赤血球症治療薬市場推計・予測：疾患タイプ別

第7章鎌状赤血球症治療薬市場の推定・予測：エンドユーザー別

第8章鎌状赤血球症治療薬市場の推定・予測：地域別

第9章企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Sickle Cell disease Treatment Market Insights

Chapter 4 Competitive Landscape, 2022

Chapter 5 Sickle Cell Disease Treatment Market Estimates and Forecast, By Treatment Modality (USD Million)

Chapter 6 Sickle Cell Disease Treatment Market Estimates and Forecast, By Disease Type (USD Million)

Chapter 7 Sickle Cell Disease Treatment Market Estimates and Forecast, By End-user (USD Million)

Chapter 8 Sickle Cell Disease Treatment Market Estimates and Forecast, By Region (USD Million)

Chapter 9 Company Profiles

鎌状赤血球症治療市場- 治療方法別、疾患別、エンドユーザー別、2023-2032年予測

Sickle Cell Disease Treatment Market - By Treatment Modality [Blood Transfusion, Pharmacotherapy (Hydroxyurea, Oxybryta, Endari), Bone Marrow Transplant], By Disease (Sickle Cell Anemia, Hemoglobin Sickle C), By End-user & Forecast, 2023-2032

目次

第1章 調査手法と調査範囲

第2章 エグゼクティブサマリー

第3章 鎌状赤血球症治療市場の洞察

第4章 競合情勢、2022年

第5章 鎌状赤血球症治療市場の推定・予測：治療方法別

第6章 鎌状赤血球症治療薬市場推計・予測：疾患タイプ別

第7章 鎌状赤血球症治療薬市場の推定・予測：エンドユーザー別

第8章 鎌状赤血球症治療薬市場の推定・予測：地域別

第9章 企業プロファイル

Data Tables

Charts & Figures

Table of Contents

Chapter 1 Methodology & Scope

Chapter 2 Executive Summary

Chapter 3 Sickle Cell disease Treatment Market Insights

Chapter 4 Competitive Landscape, 2022

Chapter 5 Sickle Cell Disease Treatment Market Estimates and Forecast, By Treatment Modality (USD Million)

Chapter 6 Sickle Cell Disease Treatment Market Estimates and Forecast, By Disease Type (USD Million)

Chapter 7 Sickle Cell Disease Treatment Market Estimates and Forecast, By End-user (USD Million)

Chapter 8 Sickle Cell Disease Treatment Market Estimates and Forecast, By Region (USD Million)

Chapter 9 Company Profiles

第1章調査手法と調査範囲

第2章エグゼクティブサマリー

第3章鎌状赤血球症治療市場の洞察

第4章競合情勢、2022年

第5章鎌状赤血球症治療市場の推定・予測：治療方法別

第6章鎌状赤血球症治療薬市場推計・予測：疾患タイプ別

第7章鎌状赤血球症治療薬市場の推定・予測：エンドユーザー別

第8章鎌状赤血球症治療薬市場の推定・予測：地域別

第9章企業プロファイル